Depression, pain, and somatoform disorders

被引:43
作者
Henningsen, P [1 ]
Löwe, B
机构
[1] Tech Univ Munich, Univ Hosp, Dept Psychosomat Med, D-81675 Munich, Germany
[2] Univ Heidelberg Hosp, Dept Psychosomat & Gen Clin Med, Heidelberg, Germany
关键词
classification; depression; pain; somatoform disorders; treatment;
D O I
10.1097/01.yco.0000189880.11059.8d
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Purpose of review The frequent co-occurrence of depression and somatic symptoms poses a continuing challenge to clinicians, researchers and experts involved in drawing up classifications. In this review we present recently published literature on aspects of epidemiology, classification and treatment in this important overlap area. Recent findings From the multitude of papers published annually on the co-occurrence of different pain conditions and depression, temporomandibular dysfunction stands out this year by sheer quantity; it can be seen as a model case of the necessity for differentiated high-quality assessments on the biological as well as the psychosocial level. There is a general move to separate utility of diagnostic classifications from their validity, and this strengthens classificatory approaches that help to view the regular overlap of depression, pain and other somatic symptoms as the rule rather than the exception. The incorporation of cognitive variables like causal attributions should help to distinguish clinically relevant subtypes among overlap cases. The classificatory future of the category of 'somatoform disorders' is somewhat in doubt, but reforms seem to be more productive than abolishment. Psychopharmacology provides rather intense recent coverage of the overlap field, with newer dual serotonergic-noradrenergic reuptake inhibitors offering some promise. Summary Treating the overlap of depression, pain and other somatic symptoms as the rule rather than the exception is necessary for adequate aetiological research as well as for diagnosis and treatment, with one-dimensional classificatory and treatment approaches almost certainly being insufficient.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 48 条
[1]   Randomized double-blind comparison of serotonergic, (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder [J].
Aragona, M ;
Bancheri, L ;
Perinelli, D ;
Tarsitani, L ;
Pizzimenti, A ;
Conte, A ;
Inghilleri, M .
EUROPEAN JOURNAL OF PAIN, 2005, 9 (01) :33-38
[2]   Somatized depression in primary care attenders [J].
Aragonés, E ;
Labad, A ;
Piñol, JL ;
Lucena, C ;
Alonso, Y .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2005, 58 (02) :145-151
[3]   A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder [J].
Arnold, LM ;
Lu, YL ;
Crofford, LJ ;
Wohlreich, M ;
Detke, MJ ;
Iyengar, S ;
Goldstein, DJ .
ARTHRITIS AND RHEUMATISM, 2004, 50 (09) :2974-2984
[4]   Impact of pain on depression treatment response in primary care [J].
Bair, MJ ;
Robinson, RL ;
Eckert, GJ ;
Stang, PE ;
Croghan, TW ;
Kroenke, K .
PSYCHOSOMATIC MEDICINE, 2004, 66 (01) :17-22
[5]   Depression and pain comorbidity - A literature review [J].
Bair, MJ ;
Robinson, RL ;
Katon, W ;
Kroenke, K .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (20) :2433-2445
[6]   Identification of somatic and anxiety symptoms to the detection of depression in primary which contribute health care [J].
Barkow, K ;
Heun, R ;
Üstün, TB ;
Berger, M ;
Bermejo, I ;
Gaebel, W ;
Härter, W ;
Schneider, F ;
Stieglitz, RD ;
Maier, W .
EUROPEAN PSYCHIATRY, 2004, 19 (05) :250-257
[7]   Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder [J].
Brannan, SK ;
Mallinckrodt, CH ;
Brown, EB ;
Wohlreich, MM ;
Watkin, JG ;
Schatzberg, AF .
JOURNAL OF PSYCHIATRIC RESEARCH, 2005, 39 (01) :43-53
[8]   Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial [J].
Detke, MJ ;
Wiltse, CG ;
Mallinckrodt, CH ;
McNamara, RK ;
Demitrack, MA ;
Bitter, I .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 (06) :457-470
[9]   Depression and comorbid pain as predictors of disability, employment, insurance status, and health care costs [J].
Emptage, NP ;
Sturm, R ;
Robinson, RL .
PSYCHIATRIC SERVICES, 2005, 56 (04) :468-474
[10]  
Fava M, 2004, J CLIN PSYCHIAT, V65, P521